![logo](/logos/PTCT.webp)
PTC Therapeutics, Inc.
NASDAQ:PTCT
31.54 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PTC Therapeutics, Inc. |
Symbool | PTCT |
Munteenheid | USD |
Prijs | 31.54 |
Beurswaarde | 2,426,189,268 |
Dividendpercentage | 0% |
52-weken bereik | 17.53 - 41.8 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Matthew B. Klein F.A.C.S., FACS, M.D., M.S., MS |
Website | https://www.ptcbio.com |
An error occurred while fetching data.
Over PTC Therapeutics, Inc.
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)